Search

NANOGENECS WINS THE DRAGON’S DEN PITCH COMPETITION AT BIOMED FINANCE FORUM

Nancy Schoenbrunner, CEO of Nanogenecs, wins first prize amongst start-up companies presenting at the BioMed Finance Forum.


MONTREAL, November 18, 2019 On November 14th, the 6th annual BIOMED Finance Forum was held at Espace CDPQ in Montreal. The forum, organized by Pharmed Canada, is a half-day conference for private and public companies in life sciences, mobile health, and healthcare to meet investors, industry analysts, bankers and other professionals in the industry. The event culminated with a Dragon’s Den-style pitch competition by selected start-ups. The panel of “dragons” included

Jean-Francois Pariseau , Co-Founder and Partner, Amplitude Ventures (Canada)Lahav Gil , CEO, Relay Medical Corp. (Israel) Maha Katabi , Partner, Sofinnova Investments (USA)Hesam Masoumi , Senior Director, Product Health and Wellness, RBC Ventures (Canada)Youssef Bennani , Venture Partner, AdMare BioInnovations (Canada)

Nancy Schoenbrunner, CEO, presented Nanogenecs’ technology and commercialization strategy. Nanogenecs was selected as the top presentation by the forum participants and as such, was rewarded by prizes from Fasken Start-Up and Emerging Company Services

CTS, and the Quebec Innovation Center for Biotechnology (CQIB) totaling $8,500 plus 20 hours of consulting.

“We are grateful for the opportunity to have pitched at the BioMed Finance Forum. The “dragons” asked tough but excellent questions. We are looking forward to working with the supporters of innovation in Quebec that have generously rewarded us,” said Nancy Schoenbrunner, CEO Nanogenecs.

About Nanogenecs

Nanogenecs is an early-stage in vitro diagnostic (IVD) company whose vision is to help patients with chronic diseases better manage their conditions. Nanogenecs is building a convenient and inexpensive portable medical diagnostic platform that measures a patient’s blood chemistry (biomarkers) in a matter of minutes from finger stick blood. Test results will be integrated with the electronic medical records and remote care plans from the patient’s health care providers to promote proactive care. Nanogenecs’ breakthrough technology of electrochemical DNA nanosensors was invented by Dr. Alexis Vallee-Belisle, Professor of Chemistry at the University of Montreal and Canada Research Chair for Biotechnology and Bionanotechnology. Nanogenecs is headquartered in Montreal with offices in Boston.

  • Nanogenecs

Headquarters 

Université de Montréal

2900 Edouard Montpetit Blvd, Montreal, QC H3T 1J4